Silicon Valley startups are pushing the boundaries of reproductive genetics, hoping to prevent diseases as well as improve chances for a high IQ ...

A Silicon Valley startup backed by OpenAI’s Sam Altman and Coinbase’s Brian Armstrong is pursuing research that some fear ...

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.

Dyne initiated the U.S. site activation process in June 2025 after submitting a revised protocol for the REC to the U.S. Food and Drug Administration (FDA) with video hand opening time (vHOT) as the ...

Celiac disease can force individuals to avoid just about anything with gluten. While this once might have meant they had to go without bread, that is no longer the case. Here are some of the best ...

A significant legal victory has emerged for consumers as a federal appeals court has ordered the United States Department of Agriculture (USDA) to revise its genetically modified food labeling ...

Normally, ENO1 is part of the body’s natural process of turning glucose into energy. However, in cancer cells, it becomes ...

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against factor XI, in patients undergoing total knee replacement Trial results cons ...

In a shocking turn of events, a twice-deported Salvadoran illegal immigrant violently attacked an ICE officer during a recent arrest in Houston, drawing renewed attention to the urgent need for ...